CA2210471A1 - Chemokine humaine beta-11 et chemokine humaine alpha-1 - Google Patents

Chemokine humaine beta-11 et chemokine humaine alpha-1

Info

Publication number
CA2210471A1
CA2210471A1 CA002210471A CA2210471A CA2210471A1 CA 2210471 A1 CA2210471 A1 CA 2210471A1 CA 002210471 A CA002210471 A CA 002210471A CA 2210471 A CA2210471 A CA 2210471A CA 2210471 A1 CA2210471 A1 CA 2210471A1
Authority
CA
Canada
Prior art keywords
polypeptide
dna
polypeptides
polynucleotide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002210471A
Other languages
English (en)
Inventor
Haodong Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002210471A priority Critical patent/CA2210471A1/fr
Publication of CA2210471A1 publication Critical patent/CA2210471A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention décrit des polypeptides de la chémokine humaine et de l'ADN (ARN) codant de tels polypeptides de chémokine, ainsi qu'un procédé pour produire ces polypeptides par des techniques de recombinaison. Elle décrit également des procédés d'utilisation de ces polypeptides de chémokine dans le traitement de la leucémie, de tumeurs, d'infections chroniques, de maladies auto-immunes, de troubles fibreux, dans la cicatrisation et le traitement du psoriasis. L'invention décrit également des antagonistes de ces polypeptides de chémokine et leur utilisation comme thérapeutique pour traiter la polyarthrite rhumatoïde, des maladies auto-immunes et des maladies inflammatoires et infectieuses chroniques et aiguës, des réactions allergiques, la fièvre indépendante de la prostaglandine et l'insuffisance médullaire. Sont également décrites des méthodes diagnostiques pour déceler des maladies liées aux mutations dans les séquences nucléotidiques et des modifications des concentrations de polypeptides. Sont également décrites des méthodes diagnostiques pour déceler des mutations dans les polynucléotides codant les polypeptides de la chémokine et des modifications des taux de polypeptide chez un hôte.
CA002210471A 1995-02-08 1995-02-08 Chemokine humaine beta-11 et chemokine humaine alpha-1 Abandoned CA2210471A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002210471A CA2210471A1 (fr) 1995-02-08 1995-02-08 Chemokine humaine beta-11 et chemokine humaine alpha-1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002210471A CA2210471A1 (fr) 1995-02-08 1995-02-08 Chemokine humaine beta-11 et chemokine humaine alpha-1

Publications (1)

Publication Number Publication Date
CA2210471A1 true CA2210471A1 (fr) 1996-08-15

Family

ID=4161069

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002210471A Abandoned CA2210471A1 (fr) 1995-02-08 1995-02-08 Chemokine humaine beta-11 et chemokine humaine alpha-1

Country Status (1)

Country Link
CA (1) CA2210471A1 (fr)

Similar Documents

Publication Publication Date Title
US6511826B2 (en) Polynucleotides encoding human G-protein chemokine receptor (CCR5) HDGNR10
AU708903B2 (en) Human chemokine polypeptides
US6743594B1 (en) Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6458349B1 (en) Chemokine β-4 polypeptides
AU723891B2 (en) Human chemokine beta-11 and human chemokine alpha-1
US20060040313A1 (en) Human chemokine beta-9
EP0832233B1 (fr) Chemokine beta-13 humaine
EP0811059A1 (fr) Chemokine humaine beta-11 et chemokine humaine alpha-1
US5981230A (en) Polynucleotide encoding chemokine β-4
WO1996039520A1 (fr) Chemokine beta-12 humaine
WO1996023410A1 (fr) Enzymes 7, 8 et 9 de conjugaison d'ubiquitine
EP1006188B1 (fr) Polypeptides de type chemokine humaine
CA2210471A1 (fr) Chemokine humaine beta-11 et chemokine humaine alpha-1
EP0777494B1 (fr) Polypeptides de type chemokine humaine
AU753088B2 (en) Human chemokine polypeptides
AU753730B2 (en) Human chemokine beta-13
AU750982B2 (en) Human chemokine beta-11 and human chemokine alpha-1
AU767527B2 (en) Human chemokine polypeptides
US20090062510A1 (en) Human Chemotactic Cytokine I Polypeptides
CA2216912A1 (fr) Recepteur hdgnr10 de chimiokine de la proteine g humaine
WO1997023640A1 (fr) Cytokine i chimiotactique de l'homme
CA2217216A1 (fr) Chemokine beta-13 humaine
JP2002320492A (ja) ヒトケモカインβ−１１およびヒトケモカインα−１
KR19990087164A (ko) 사람 케모킨 폴리펩티드
AU2004200581A1 (en) Human chemokine polypeptides

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued